In the BioHarmony Drug Report Database
Bepotastine besilate
Bepreve (bepotastine besylate) is a small molecule pharmaceutical. Bepotastine besylate was first approved as Bepreve on 2009-09-08. Bepreve’s patent is valid until 2025-01-13 (FDA).
Trade Name
|
Bepreve |
|---|---|
Common Name
|
bepotastine besylate |
ChEMBL ID
|
CHEMBL1201759 |
Indication
|
|
Drug Class
|
Antihistaminics (histamine-H1 receptor antagonists) |
Image (chem structure or protein)